PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL OR TRANSMUCOSAL ADMINISTRATION
The invention relates to a novel pharmaceutical composition for transdermal or transmucosal administration using at least one active substance, particularly comprising a fatty acid as percutaneous absorption promoter, at least one alcoholic vehicle and a stabilising agent which can stabilise said fatty acid in said pharmaceutical composition.